Three drug companies—Boehringer Ingelheim, AstraZeneca, and Novo Nordisk—allege that guidance on the Medicare Drug Price Negotiation Program issued by the Centers for Medicare and Medicaid Services ...

As many have now heard, on Thursday, August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) released the prices for the first 10 prescription drugs selected for negotiation with ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...

ALEXANDRIA, Va.--(BUSINESS WIRE)--Today, the National Community Pharmacists Association released a first-of-its-kind analysis, Unpacking the Financial Impacts of Medicare Drug Price Negotiation, ...

The U.S. Department of Health and Human Services unveiled 15 additional drugs chosen for the Medicare Drug Price Negotiation Program on Friday. Many healthcare leaders are applauding the list of ...

Today, the U.S. Supreme Court issued an order list denying a series of petitions for writ of certiorari filed by major pharmaceutical developers to challenge the Medicare negotiation program ...

Medicare’s historic drug price negotiation program has survived its first court challenge by a drugmaker. A federal district court judge in Delaware on Friday rejected AstraZeneca’s claims that the ...

The Trump administration signaled Medicare drug price negotiations under the Inflation Reduction Act (IRA) signed in 2022 by former President Joe Biden may undergo a reexamination to add greater ...

“The Program cannot qualify as a physical taking under the Takings Clause because it does not ‘compel the surrender’ of property, or impose any ‘physical invasion or restraint upon’ it, and the owner ...